← Leaderboards
Katherine C. Macnamara
Nysdoh/Health Research, Inc.
$6,709,253
Attributed
$8,130,346
Total exposure
7
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.7M · FY2008–25$2M$1.5M$1M$500K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,130,346 · 7
By mechanism
R01$5,374,392 · 3
R35$2,025,000 · 1
R21$629,598 · 2
F32$101,356 · 1
Top collaborators
- Gabrielle Fredman3 shared
- Yi-Pin Lin2 shared
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsProductionInflammatoryBloodBone MarrowInfectionInflammationImmuneMortalityImpairmentHost DefenseExhibitsFunctional DisorderInsightBiologicalLifeProgramsBurden Of IllnessHematopoietic Stem CellsPredispositionHematopoieticImmune SystemNovel TherapeuticsReceptor
Grant awards (21)
Inflammation-resolution impairments in aging and atherosclerosis$795,777
R01 · FY2025 · HL
Improving Inflammation Resolution to Mitigate Acquired Bone Marrow Failure$493,796
R01 · FY2025 · HL · contact PI
Specialized Pro-Resolving Lipid Mediators for Systemic Radiation Countermeasures$164,000
R21 · FY2025 · AI · contact PI
Inflammation-resolution impairments in aging and atherosclerosis$778,674
R01 · FY2024 · HL
Improving Inflammation Resolution to Mitigate Acquired Bone Marrow Failure$487,221
R01 · FY2024 · HL · contact PI
Inflammation-resolution impairments in aging and atherosclerosis$802,138
R01 · FY2023 · HL
Improving Inflammation Resolution to Mitigate Acquired Bone Marrow Failure$515,786
R01 · FY2023 · HL · contact PI
Hematopoietic Stem Cell Dysfunction and Regeneration in Severe Infection$405,000
R35 · FY2023 · GM · contact PI
Hematopoietic Stem Cell Dysfunction and Regeneration in Severe Infection$405,000
R35 · FY2022 · GM · contact PI
Hematopoietic Stem Cell Dysfunction and Regeneration in Severe Infection$405,000
R35 · FY2021 · GM · contact PI
Early Host Responses During Co-Infection of Tick-Borne Pathogens$205,469
R21 · FY2021 · AI · contact PI
Hematopoietic Stem Cell Dysfunction and Regeneration in Severe Infection$405,000
R35 · FY2020 · GM · contact PI
Early Host Responses During Co-Infection of Tick-Borne Pathogens$260,129
R21 · FY2020 · AI · contact PI
Hematopoietic Stem Cell Dysfunction and Regeneration in Severe Infection$405,000
R35 · FY2019 · GM · contact PI
HSC function during infection$300,200
R01 · FY2018 · GM · contact PI
HSC function during infection$300,200
R01 · FY2017 · GM · contact PI
HSC function during infection$300,200
R01 · FY2016 · GM · contact PI
HSC function during infection$300,200
R01 · FY2015 · GM · contact PI
HSC function during infection$300,200
R01 · FY2014 · GM · contact PI
Interferon gamma Regulation of CD4 T Cell Responses in Tuberculosis$51,710
F32 · FY2009 · AI · contact PI
Interferon gamma Regulation of CD4 T Cell Responses in Tuberculosis$49,646
F32 · FY2008 · AI · contact PI